Correlation Between Syndax Pharmaceuticals and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Travere Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Travere Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Travere Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Syndax and Travere is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Travere Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Syndax Pharmaceuticals is 1.19 times less risky than Travere Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 799.00 in Travere Therapeutics on December 5, 2024 and sell it today you would earn a total of 1,171 from holding Travere Therapeutics or generate 146.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. Travere Therapeutics
Performance |
Timeline |
Syndax Pharmaceuticals |
Travere Therapeutics |
Syndax Pharmaceuticals and Travere Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and Travere Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |